ArticleCell death & disease2026
m
Yingmin Wu, Shenjie Zhang, Shilong Zhang, Jieyu Lu, Yuntao Yang, Zhirui Zeng, Shan Lei, Rui Mi, Yewei Zhang, Lichen Ge and 2 more
Abstract read
In one paragraphArticle in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Shenjie Zhang *Department of Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Shilong Zhang *Department of Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Jieyu LuDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.
Yuntao YangDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.
Shan LeiDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.
Rui MiDepartment of Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Yewei ZhangDepartment of Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Funding
China Postdoctoral Science Foundation 2021M700971Department of Education of Guizhou Province (Guizhou Provincial Department of Education) [2022]109Department of Health of Guizhou Province (Guizhou Provincial Department of Health) QJJ[2022]191Guizhou Science and Technology Department (Department of Science and Technology, Guizhou Province) ZD[2026]125Guizhou Science and Technology Department (Department of Science and Technology, Guizhou Province) ZK[2022]390National Natural Science Foundation of China (National Science Foundation of China) 82103296National Natural Science Foundation of China (National Science Foundation of China) 82260606
6 · The paper itselfAbstract
Liver cancer remains one of the leading causes of cancer-related mortality worldwide, with its progression driven by uncontrolled cell proliferation and evasion of apoptosis. N1-methyladenosine (m
Indexed as
AdenosineApoptosisInhibitor of Apoptosis ProteinsLiver NeoplasmsRNA StabilityAnimalsCell Line, TumorCell ProliferationDisease ProgressionExoribonucleasesGene Expression Regulation, NeoplasticHumansMiceMice, NudeRNA-Binding ProteinsRNA, MessengerAdenosineBIRC2 protein, humanExoribonucleasesInhibitor of Apoptosis ProteinsRNA-Binding ProteinsRNA, MessengerUbiquitin-Protein Ligases
Identifiers
PMID41991508
PMCPMC13350948
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390